The FDA shortage database listed semaglutide as in shortage from March 2022 until February 2025, allowing legal compounding under federal regulations
Research suggests that MUFAs, such as those found in extra virgin olive oil and avocados are more potent triggers for GLP-1 secretion than saturated fats
But it is the kind of number that gets Phase 3 budgets approved
Genetic testing through a clinical partner like PlexusDx may add value if you want biomarker context, but it should complement, not replace, a thorough clinical assessment
Pancreatic alpha-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation
Her kindness and outstanding professionalism are truly INCREDIBLE." Chicago, IL "From the moment I walked in, the atmosphere was welcoming and relaxing